Vaneltix Pharma, Inc.

This study tests a single dose of a new drug called VNX001 to see if it quickly reduces moderate to severe bladder pain in people with interstitial cystitis (also called bladder pain syndrome). About 120 adults with a history of this condition will receive either VNX001, a placeb…

This study tests a drug called VNX001 for people with Interstitial Cystitis (a condition causing bladder pain) who have sudden, moderate-to-severe pain. About 50 adults will receive up to 6 doses of the drug through a catheter over 14 days. The goal is to see if the drug safely r…